Network Biology 2.0

Connecting Genomes to Disease Progression & Drug Response

Gene Network Sciences, The Broad Institute and The Boston Area Systems and Synthetic Biology group are again presenting Network Biology 2.0: Connecting Genomes to Disease Progression and Drug Response. This edition of Network Biology 2.0 will address the current state-of-the art in technologies, approaches, and results in the field of network biology which demonstrate network biology's impact on biomedical research, drug discovery and development, and healthcare.

Who may register

Registration is now open. This symposium is open to and free for the health care, biopharma and network biology communities. Space is limited; please register early.

When & Where

  • April 14-15th, at the Broad Institute, 7 Cambridge Center, Cambridge, MA.
  • April 14th will start at 8:00 AM and includes breakfast, lunch & an evening reception.
  • April 15th will start at 7:30 AM and includes breakfast & lunch.
  • An all day espresso & coffee bar will also be open both days.

Symposium Description

The 2010 Network Biology 2.0 symposium will address the current state of the art in technologies, approaches, and results in the field of network biology which demonstrate network biology's impact on biomedical research, drug discovery and development, and healthcare. Leading researchers in the field will provide an overview of computational approaches to unravelling complex genetic and molecular networks underlying whole systems disease physiology. The talks will focus on integrative genomics approaches that use multi-dimensional data – from genetic variation, to molecular changes, and then to physiological outcomes. The symposium will also discuss new technologies, such as next-generation DNA sequencing, and explore large scale genetic and 'omic data collection efforts in relevant model disease systems and human clinical cohorts. The conference will highlight prominent efforts in academia, industry, and the convergence between academic and industry efforts.

This year's event focuses on the field of oncology, where a plethora of genomic data is being generated, and where the transition to predictive and personalized medicine is well underway. We will also hold a special session on Web 2.0 applications in medicine, health care, and biomedical research, which are becoming instrumental in addressing the key bottleneck of acquiring data from patient cohorts necessary for network biology approaches.


Speakers & Presenters:

  • Linda Avey, Brainstorm Research Foundation
  • Mark Boguski, Beth Israel Deaconess
  • Alexis Borisy, Third Rock Ventures
  • Andrea Califano, Columbia
  • John Carulli, Biogen Idec
  • George Church, Harvard Medical
  • James J. Collins, Boston U/Howard Hughes
  • Kevin Davies, BioIT World
  • Nicholas Eriksson, 23andMe
  • Todd Golub, Broad/Dana-Farber
  • James Heywood, PatientsLikeMe
  • W. Michael Korn, UCSF Medical Center
  • Tarjei S. Mikkelsen, Broad Institute
  • Vamsi Mootha, Harvard Med/Broad
  • Eric Perakslis, Johnson & Johnson
  • Sridhar Ramaswamy, Harvard Medical
  • Aviv Regev, Broad/Howard Hughes
  • Eric E. Schadt, Pacific Biosciences/Sage
  • William R. Sellers, Novartis
  • Peter Sorger, Harvard Medical
  • Stephen Turner, Pacific Biosciences
  • Marc Vidal, Harvard Med/Dana Farber
  • Robert A. Weinberg, Whitehead Institute